The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study
Description
Tocilizumab (TCZ) is recommended in patients with COVID-19 who require oxygen therapy or ventilatory support. Despite the wide use of TCZ, little is known about its safety and effectiveness in patients with COVID-19 and renal impairment. Therefore